Bone mass and bone metabolism in pediatric gastrointestinal disorders

Journal of Pediatric Gastroenterology and Nutrition

Volumn 39, Issue 2, 2004, Pages 129-140

  Mora, Stefano ^a   Barera, Graziano ^a  

^a NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; BONE DENSITY; BONE DEVELOPMENT; CHILD; CHILD DEVELOPMENT; GASTROINTESTINAL DISEASE; HUMAN; METABOLIC BONE DISEASE; METABOLISM; OSTEOPOROSIS; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

BONE AND BONES; BONE DENSITY; BONE DEVELOPMENT; BONE DISEASES, METABOLIC; CHILD; CHILD DEVELOPMENT; GASTROINTESTINAL DISEASES; HUMANS; OSTEOPOROSIS;

EID: 16644399773     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/00005176-200408000-00002     Document Type: Review

References (108)

1. McKiggan JJ. Metabolic bone disease and the gastrointestinal tract. N S Med Bull 1966;45:329-31.
2. Consensus Development Conference. Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 1993;94:646-50.
3. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO study group. World Health Organ Tech Rep Ser 1994;843:1-129.
4. Goulding A, Jones IE, Taylor RW, et al. More broken bones: a 4-year double cohort study of young girls with and without distal forearm fractures. J Bone Miner Res 2000;15:2011-8.
5. Skaggs DL, Loro ML, Pitukcheewanont P, et al. Increased body weight and decreased radial cross-sectional dimensions in girls with forearm fractures. J Bone Miner Res 2001;16:1337-42.
6. Mora S, Gilsanz V. Establishment of peak bone mass. Endocrinol Metab Clin N Am 2003;32:39-63.
7. Trotter M, Hixon BB. Sequential changes in weight, density, and percentage ash weight of human skeletons from an early fetal period through old age. Anat Rec 1974;179:1-18.
8. Bailey DA, McKay HA, Mirwald RL, et al. A six-year longitudinal study of the relationship of physical activity to bone mineral accrual in growing children: The University of Saskatchewan bone mineral accrual study. J Bone Miner Res 1999;14:1672-9.
9. Riggs BL, Wahner HW, Dunn WL, et al. Differential changes in bone mineral density of the appendicular skeleton with aging. J Clin Invest 1981;67:328-35.
10. Mora S, Goodman WG, Loro ML, et al. Age-related changes in cortical and cancellous vertebral bone density in girls: assessment with quantitative CT. Am J Roentgenol 1994;162:405-9.
11. Christian JC, Yu PL, Slemenda CW, Johnston CC. Heritability of bone mass: A longitudinal study in ageing male twins. Am J Hum Genet 1989;44:429-33.
12. Seeman E, Hopper JL, Bach LA, et al. Reduced bone mass in daughters of women with osteoporosis. N Engl J Med 1989;320:554-8.
13. Pocock NA, Eisman JA, Hopper JL, et al. Genetic determinants of bone mass. A twin study. J Clin Invest 1987;80:706-10.
14. Seeman E. Sexual dimorphism in skeletal size, density, and strength. J Clin Endocrinol Metab 2001;86:4576-84.
15. Mora S, Bachrach L, Gilsanz V. Noninvasive techniques for bone mass measurement. In: Glorieux FH, Pettifor JM, Jüppner H, eds. Pediatric Bone. Biology and Disease. San Diego: Academic Press, 2003:303-24.
16. Schönau E. Problems of bone analysis in childhood and adolescence. Pediatr Nephrol 1998;12:420-9.
17. Gilsanz V. Bone density in children: a review of the available techniques and indications. Eur J Radiol 1998;26:177-82.
18. Bass S, Delmas PD, Pearce G, et al. The differing tempo of growth in bone size, mass, and density in girls is region-specific. J Clin Invest 1999;104:795-804.
19. Theintz G, Buchs B, Rizzoli R, et al. Longitudinal monitoring of bone mass accumulation in healthy adolescents: Evidence for a marked reduction after age 16 years of age at the levels of lumbar spine and femoral neck in female subjects. J Clin Endocrinol Metab 1992;75:1060-5.
20. Bachrach LK, Hastie T, Wang M-C, et al. Bone mineral acquisition in healthy Asian, Hispanic, Black and Caucasian youth. A longitudinal study. J Clin Endocrinol Metab 1999;84:4702-12.
21. Carter DR, Bouxsein ML, Marcus R. New approaches for interpreting projected bone densitometry data. J Bone Miner Res 1992;7:137-45.
22. Hangartner TN. Influence of fat on bone measurements with dual-energy absorptiometry. Bone Miner 1990;9:71-8.
23. Cann CE, Genant HK. Precise measurement of vertebral mineral content using computed tomography. J Comput Assist Tomogr 1980;4:493-500.
24. Hangartner TN, Overton TR. Quantitative measurement of bone density using gamma-ray computed tomography. J Comput Assist Tomogr 1982;6:1156-62.
25. Hangartner TN, Gilsanz V. Evaluation of cortical bone by computed tomography. J Bone Miner Res 1996;11:1518-25.
26. Neu CM, Manz F, Rauch F, et al. Bone densities and bone size at the distal radius in healthy children and adolescents: a study using peripheral quantitative computed tomography. Bone 2001;28:227-32.
27. Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 2000;21:115-37.
28. Saag KG. Glucocorticoid-induced osteoporosis. Endocrinol Metab Clin N Am 2003;32:135-57.
29. Raisz LG, Rodan GA. Pathogenesis of osteoporosis. Endocrinol Metab Clin N Am 2003;32:15-24.
30. Frost HM. Skeletal structural adaptations to mechanical usage (SATMU): 1. Redefining Wolff’s law: the bone modeling problem. Anat Rec 1990;226:403-13.
31. Frost HM. Skeletal structural adaptations to mechanical usage (SATMU): 2. Redefining Wolff’s law: the remodeling problem. Anat Rec 1990;226:414-22.
32. Glorieux FH, Travers R, Taylor A, et al. Normative data for iliac bone histomorphometry in growing children. Bone 2000;26:103-9.
33. Shönau E, Rauch F. Biochemical markers of bone metabolism. In: Glorieux FH, Pettifor JM, Jüppner H, eds. Pediatric Bone. Biology and disease. San Diego: Academic Press, 2003:339-57.
34. Whyte MP. Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization. Endocr Rev 1994;15:439-61.
35. Eyre DR, Paz MA, Gallop PM. Cross-linking in collagen and elastin. Annu Rev Biochem 1984;53:717-48.
36. Bonde M, Qvist P, Fledelius C, et al. Immunoassays for quantifying type I collagen degradation products in urine evaluated. Clin Chem 1994;40:2022-5.
37. Calvo MS, Eyre DR, Gundberg CM. Molecular basis and clinical application of biological markers of bone turnover. Endocr Rev 1996;17:333-68.
38. Blumsohn A, Hannon RA, Wrate R, et al. Biochemical markers of bone turnover in girls during puberty. Clin Endocrinol 1994;40:663-70.
39. Mora S, Prinster C, Proverbio MC, et al. Urinary markers of bone turnover in healthy children and adolescents: age-related changes and effect of puberty. Calcif Tissue Int 1998;63:369-74.
40. Mora S, Pisitukcheewanont P, Kaufman FR, et al. Biochemical markers of bone turnover and the volume and the density of bone in children at different stages of sexual development. J Bone Miner Res 1999;14:1664-71.
41. Salvesen HA, Boe J. Osteomalacia in sprue. Acta Med Scand 1953;146:290-299.
42. Moss AJ, Waterhouse C, Terry R. Gluten sensitive enteropathy with osteomalacia but without steatorrhea. N Engl J Med 1965;272:825-30.
43. Kruse HP, Ringe JD, Tomforde-Brunckhorst R. Non-tropical sprue, a frequently unrecognized cause of high-grade generalized osteopathy. Dtsch Med Wochenschr 1987;112:1155-9.
44. Mora S, Weber G, Barera G, et al. Effect of gluten-free diet on bone mineral content in growing patients with celiac disease. Am J Clin Nutr 1993;57:224-8.
45. Mora S, Barera G, Ricotti A, et al. Reversal of low bone density with a gluten-free diet in children and adolescents with celiac disease. Am J Clin Nutr 1998;67:477-81.
46. Kalayci AG, Kansu A, Girgin N, et al. Bone mineral density and importance of a gluten-free diet in patients with celiac disease in childhood. Pediatrics 2001;08:e89.
47. Scotta MA, Salvatore S, Salvatoni A, et al. Bone mineralization and body composition in young patients with celiac disease. Am J Gastroenterol 1997;92:1331-4.
48. Kavak US, Yüce A, Koçak, et al. Bone mineral density in children with untreated and treated celiac disease. J Pediatr Gastroenterol Nutr 2003;37:434-6.
49. Bayer M, Stepan JJ, Sedlackova M, et al. Spinal bone mineral density in children with celiac disease. J Clin Densitom 1998;1:125-36.
50. Karkoszka H, Kalita B, Wiecek A, et al. Influence of gluten free diet on bone mineral density (BMD) in children with celiac disease. Przegl Lek 2000;57:330-3.
51. Mora S, Barera G, Beccio S, et al. A prospective, longitudinal study of the long-term effect of treatment on bone density in children with celiac disease. J Pediatr 2001;139:516-21.
52. Sdepanian VL, Noronha de Miranda Carvalho C, Batista de Morais M, Basile Colugnati FA, Fagundes-Neto U. Bone mineral density of the lumbar spine in children and adolescents with celiac disease on a gluten-free diet in São Paulo, Brazil. J Pediatr Gastroenterol Nutr 2003;37:571-6.
53. Pedrera JD, López MJ, Canal ML, et al. Quantitative phalangeal bone ultrasound is normal after long-term gluten-free diet in young coeliac patients. Eur J Gastroenterol Hepatol 2001;13:1169-73.
54. Szathmári M, Tulassay T, Arató A, et al. Bone mineral content and density in asymptomatic children with coeliac disease on a gluten-free diet. Eur J Gastroenterol Hepatol 2001;13:419-24.
55. Molteni N, Caraceni MP, Bardella MT, et al. Bone mineral density in adult celiac patients and the effect of gluten-free diet from childhood. Am J Gastroenterol 1990;85:51-3.
56. Mora S, Barera G, Beccio S, et al. Bone density and bone metabolism are normal after long-term gluten-free diet in young celiac patients. Am J Gastroenterol 1999;94:398-403.
57. Praticò G, Caltabiano L, Bottaro G, et al. Serum levels of osteocalcin and type I procollagen in children with celiac disease. J Pediatr Gastroenterol Nutr 1997;24:170-3.
58. Barera G, Beccio S, Proverbio MC, Mora S. Longitudinal changes of bone metabolism and bone mineral content in children with celiac disease during consumption of a gluten-free diet. Am J Clin Nutr 2004;79:148-154.
59. Cowan FJ, Warner JT, Dunstan FDJ, et al. Inflammatory bowel disease and predisposition to osteopenia. Arch Dis Child 1997;76:325-9.
60. Boot AM, Bouquet J, Krenning EP, de Muinck Keizer-Schrama SMPF. Bone mineral density and nutritional status in children with chronic inflammatory bowel disease. Gut 1998;42:188-94.
61. Gokhale R, Favus MJ, Karrison T, et al. Bone mineral density assessment in children with inflammatory bowel disease. Gastro-enterology 1998;114:902-11.
62. Issenman RM, Atkinson SA, Radoja C, Fraher L. Longitudinal assessment of growth, mineral metabolism, and bone mass in pediatric Crohn’s disease. J Pediatr Gastroenterol Nutr 1993;17:401-6.
63. Herzog D, Bishop N, Glorieux F, Seidman EG. Interpretation of bone mineral density values in pediatric Crohn’s disease. Inflamm Bowel Dis 1998;4:261-7.
64. Semeao EJ, Jawad AF, Zemel BS, et al. Bone mineral density in children and young adults with Crohn’s disease. Inflamm Bowel Dis 1999;5:161-6.
65. Levine A, Mishna L, Ballin A, et al. Use of quantitative ultrasound to assess osteopenia in children with Crohn’s disease. J Pediatr Gastroenterol Nutr 2002;35:169-72.
66. Kutílek S, Bayer M, Fruhauf P. Growth failure and decreased ultrasound parameters of bone density in children with inflammatory bowel disease. Nutrition 2001;17:83.
67. Cowan FJ, Parker DR, Jenkins HR. Osteopenia in Crohn’s disease. Arch Dis Child 1995;73:255-6.
68. Semeao EJ, Stallings VA, Peck SN, Piccoli DA. Vertebral compression fractures in pediatric patients with Crohn’s disease. Gastroenterology 1997;112:1710-3.
69. Thearle M, Horlick M, Bilezikian JP, et al. Osteoporosis. An unusual presentation of childhood Crohn’s disease. J Clin Endocrinol Metab 2000;85:2122-6.
70. Semeao EJ, Jawad AF, Stouffer NO, et al. Risk factors for low bone mineral density in children and young adults with Crohn’s disease. J Pediatr 1999;135:593-600.
71. Sentongo TA, Semeao EJ, Stettler N, et al. Vitamin D status in children, adolescents, and young adults with Crohn’s disease. Am J Clin Nutr 2002;76:1077-81.
72. Hahn TJ, Squires AE, Halstead LR, Strominger DB. Reduced serum 25-hydroxyvitamin D concentration and disordered mineral metabolism in patients with cystic fibrosis. J Pediatr 1979;94:38-42.
73. Reiter EO, Brugman SM, Pike JW, et al. Vitamin D metabolites in adolescents and young adults with cystic fibrosis: Effects of sun and season. J Pediatr 1985;106:21-6.
74. Henderson RC, Madsen CD. Bone density in children and adolescents with cystic fibrosis. J Pediatr 1996;128:28-34.
75. Humphries IRJ, Allen JR, Waters DL, et al. Volumetric bone mineral density in children with cystic fibrosis. Appl Radiat Isot 1998;49:593-5.
76. Bhudhikanok GS, Wang M-C, Marcus R, et al. Bone acquisition and loss in children and adults with cystic fibrosis: A longitudinal study. J Pediatr 1998;133:18-27.
77. Fok J, Brown NE, Zuberbuhler P, et al. Low bone mineral density in cystic fibrosis patients. Can J Diet Pract Res 2002;63:192-7.
78. Salamoni F, Roulet M, Gudinchet F, et al. Bone mineral content in cystic fibrosis patients: Correlation with fat-free mass. Arch Dis Child 1996;74:314-8.
79. Sood M, Hambleton G, Super M, et al. Bone status in cystic fibrosis. Arch Dis Child 2001;84:516-20.
80. Baroncelli GI, De Luca F, Magazzù G, et al. Bone demineralization in cystic fibrosis: evidence of imbalance between bone formation and degradation. Pediatr Res 1997;41:397-403.
81. Henderson RC, Madsen CD. Bone mineral content and body composition in children and young adults with cystic fibrosis. Pediatr Pulmunol 1999;27:80-4.
82. Laursen EM, MØlgaard C, Michaelsen KF, et al. Bone mineral status in 134 patients with cystic fibrosis. Arch Dis Child 1999;81:235-40.
83. Hardin DS, Arumugam R, Seilheimer DK, et al. Normal bone mineral density in cystic fibrosis. Arch Dis Child 2001;84:363-8.
84. Haslam RHM, Borovnicar DJ, Stroud DB, et al. Correlates of prepubertal bone mineral density in cystic fibrosis. Arch Dis Child 2001;85:166-71.
85. Gibbens DT, Gilsanz V, Boechat MI, et al. Osteoporosis in cystic fibrosis. J Pediatr 1988;113:295-300.
86. Greer RM, Buntain HM, Potter JM, et al. Abnormalities of the PTH-vitamin D axis and bone turnover markers in children, adolescents and adults with cystic fibrosis: Comparison with healthy controls. Osteoporos Int 2003;14:404-11.
87. Molteni N, Bardella MT, Vezzoli G, et al. Intestinal calcium absorption as shown with stable strontium test in celiac disease before and after gluten-free diet. Am J Gastroenterol 1995;90:2025-8.
88. Corazza R, Di Sario A, Cecchetti L, et al. Bone mass and metabolism in patients with celiac disease. Gastroenterology 1995;109:122-8.
89. Keaveny AP, Freaney R, McKenna MJ, et al. Bone remodeling indices and secondary hyperparathyroidism in celiac disease. Am J Gastroenterol 1996;91:1226-31.
90. Rude RK, Olerich M. Magnesium deficiency: possible role in osteoporosis associated with gluten-sensitive enteropathy. Osteporos Int 1996;6:453-61.
91. Pedreira S, Vazquez H, Sugai E, et al. Clinical significance of anti-smooth muscle antibody (SMA) fluorescence in patients with celiac disease. Gastroenterology 2000;188:A363.
92. Sugai E, Cherñavsky A, Pedreira S, et al. Bone-specific antibodies in sera from patients with celiac disease: characterization and implications in osteoporosis. J Clin Immunol 2002;22:353-62.
93. Barera G, Villa I, Menni L, et al. Non-nutritional factors are involved in bone cells dysfunction in celiac disease. Gastroenterology 2001;120:A394.
94. Fornari MC, Pedreira S, Niveloni S, et al. Pre- and post-treatment serum levels of cytokines IL-1beta, IL-6, and IL-1 receptor antagonist in celiac disease. Are they related to the associated osteopenia?Am J Gastroenterol 1998;93:413-8.
95. Sylvester FA, Wyzga N, Hyams JS, Gronowicz GA. Effect of Crohn’s disease on bone metabolism in vitro: a role for interleukin-6. J Bone Miner Res 2002;17:695-702.
96. Hyams JS, Wyzga N, Kreutzer DL, et al. Alterations of bone metabolism in children with inflammatory bowel disease: An in vitro study. J Pediatr Gastroenterol Nutr 1997;24:289-95.
97. Varghese S, Wyzga N, Griffiths AM, Sylvester FA. Effects of serum from children with newly diagnosed Crohn’s disease on primary cultures of rat osteoblasts. J Pediatr Gastroenterol Nutr 2002;35:641-8.
98. Weinstein RS, Jilka RL, Parfittt AM, et al. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 1998;102:274-82.
99. Hofbauer LC, Gori F, Riggs BL, et al. Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology 1999;140:4382-9.
100. Pantelakis SN, Sinaniotis CA, Sbirakis S, et al. Night and day growth hormone levels during treatment with corticosteroids and corticotrophin. Arch Dis Child 1972;47:605-8.
101. Kamischke A, Kemper DE, Castel MA, et al. Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy. Eur Respir J 1998;11:41-5.
102. Sakakura M, Takebe K, Nakagawa S. Inhibition of luteinizing hormone secretion induced by synthetic LRH by long-term treatment with glucocorticoids in human subjects. J Clin Endocrinol Metab 1975;40:774-9.
103. Rooney M, Davies UM, Reeve J, et al. Bone mineral content and bone mineral metabolism: changes after growth hormone treatment in juvenile chronic arthritis. J Rheumatol 2000;27:1073-81.
104. Touati G, Ruiz JC, Porquet D, et al. Effects on bone metabolism of one year recombinant human growth hormone administration to children with juvenile chronic arthritis undergoing chronic steroid therapy. J Rheumatol 200;27:1287-93.
105. Adachi JD, Bensen WG, Brown J, et al. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med 1997;337:382-7.
106. Haderslev KV, Tjellesen L, Sorensen HA, Staun M. Alendronate increases lumbar spine bone mineral density in patients with Crohn’s disease. Gastroenterology 2000;119:639-46.
107. von Tirpitz, Klaus J, Steinkamp M, et al. Therapy of osteoporosis in patients with Crohn’s disease: a randomized study comparing sodium fluoride and ibandronate. Aliment Pharmacol Ther 2003;17:807-17.
108. Glorieux FH, Bishop NJ, Plotkin H, et al. Cyclic administration of pamidronate in children with osteogenesis imperfecta. N Engl J Med 1998;339:947-52.